Webinar Overview
Join us for an insightful webinar focused on how PET imaging and reporter gene tracking are transforming CAR-T cell therapy in oncology. CAR-T therapy has shown great promise for treating cancers that are resistant to traditional therapies, but tracking the success and persistence of the treatment can be tricky. In this session, we’ll explore how PET imaging, paired with reporter gene tracking, can provide a clearer picture of CAR-T cell behaviour and help optimize therapy.
thursday, 15 May 2025
04:00 PM CEST
Key takeaways
- How PET imaging helps visualize CAR-T cells and their ability to target tumours.
- The role of reporter gene tracking in improving the accuracy of CAR-T cell monitoring.
- How we’re overcoming challenges in optimizing CAR-T therapy through imaging
- Where the future of CAR-T therapy and imaging is headed.
Who Should Attend
This webinar is perfect for anyone working or interested in oncology, immunotherapy, and biomedical imaging. If you’re involved in CAR-T cell therapy, whether in research, clinical trials, or development, you’ll find value in the discussion. It’s also a great opportunity for those interested in how imaging technologies can push cancer treatments forward.
Speakers
Mark Sellmyer MD; PhD
PI for Sellmyer lab at University of Pennsylvania
Dr. Mark A. Sellmyer, a leader in molecular imaging and theranostics at the University of Pennsylvania, has spent much of his career bridging the gap between preclinical research and its clinical application. His work focuses on advancing imaging technologies, particularly in the development of CAR-T therapies for cancer treatment.
Eric Blankemeyer BSc
Technical Director, SAIF Nuclear Medicine Core
Eric is currently, the Technical Director of the Small Animal Imaging Facility. His responsibilities include animal imaging, development of imaging protocols, and maintenance of the PET, SPECT, and CT scanners in the lab. Eric has a BSc in Biological Sciences from Rutgers University
Moderator
Etlir Xharra MSc
Application scientist at Bruker > CUBES
Etlir Xharra is an Application Scientist at Bruker’s Cubes division. With a background in genetic manipulation, oncology, and immunology, he brings scientific expertise to preclinical imaging. His role includes customer support, demos, onsite training, and R&D contributions, helping researchers optimize imaging for their studies.